6ABDEL-RAHMAN SM,AMIDON GL,KAUL A, et al. Summa-ry of the National Institute of child health and human develop-ment-best pharmaceuticals for Children Act Pediatric formulationinitiatives workshop-pediatric biopharmaceutics classification sys-tem working group[ J]. Clin Ther,2012,34(11) :S11 - S24.
7FUNK RS, BROWN JT,ABDEL-RAHMAN SM. Pediatric phar-macokinetics: human development and drug disposition[ J]. Ped-iatr Clin North Am, 2012,59(5) :1001 - 1016.
8CELLA M. Paediatric drug development: are population modelspredictive of pharmacokinetics across paediatric populations[ J].Br J Clin Pharmacol, 2011 , 72 (3 ) : 454 - 464.
9RICCI BM. Bridging studies in support of oral pediatric formula-tion development [ J] . Int J Pharm, 2013 , 457(1 ) :323 - 326.
10STRICKLEY RG, IWATA Q, WU S, et al. Pediatric drugs-a re-view of commercially available oral formulations [ J ]. J PharmSci,2007,97(5) :1731 - 1774.
